Anti-pd-l1 antibodies and their use to enhance t-cell function

C - Chemistry – Metallurgy – 07 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07K 16/28 (2006.01) A61K 39/395 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2740806

The present application relates to anti-PD-L1 antibodies, nucleic acid encoding the same, therapeutic compositions thereof, and their use enhance T-cell function to upregulate cell-mediated immune responses and for the treatment of T cell dys-functional disorders, including infection (e.g., acute and chronic) and tumor immunity.

La présente invention concerne des anticorps anti-PD-L1, un acide nucléique les codant, leurs compositions thérapeutiques et leur utilisation pour améliorer la fonction des lymphocytes T en vue de réguler positivement les réponses immunitaires à médiation cellulaire et pour le traitement de troubles dysfonctionnels des lymphocytes T, y compris une infection (par ex. aiguë et chronique) et l'immunité tumorale.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Anti-pd-l1 antibodies and their use to enhance t-cell function does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Anti-pd-l1 antibodies and their use to enhance t-cell function, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-pd-l1 antibodies and their use to enhance t-cell function will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1591999

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.